Analystreport

Cancer Genetics Inc (NASDAQ: CGIX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

CANCER GENETICS  (CGIX) 
Last cancer genetics earnings: 11/19 04:16 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cancergenetics.com